Pulnovo Medical
Develops interventional therapies for pulmonary hypertension and heart failure
$100MStrategic
Role not disclosedQV
Qiming Venture Partners
Activity from announced rounds
Activity in this selectionUndisclosed
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 2 First participation on record · 1 follow-on
- Funding in participating rounds
- $282.5M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionOricell Therapeutics
Develops next-generation cell therapies for oncology and immunology
$110MPre-IPO
Role not disclosedStairMed
Develops minimally invasive implantable brain-machine interfaces (BMI) for neurological diseases
CN¥500MStrategic
Role not disclosed